Filing Details
- Accession Number:
- 0000908662-15-000296
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-08-19 16:14:51
- Reporting Period:
- 2015-08-17
- Filing Date:
- 2015-08-19
- Accepted Time:
- 2015-08-19 16:14:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 907562 | Dyax Corp | DYAX | Services-Commercial Physical & Biological Research (8731) | 043053198 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1134365 | V George Migausky | C/O Dyax Corp. 55 Network Drive Burlington MA 01803-2756 | Evp & Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-08-17 | 65,000 | $3.22 | 136,350 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-08-17 | 51,000 | $10.20 | 187,350 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-08-17 | 64,291 | $22.60 | 123,059 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-08-17 | 51,709 | $23.17 | 71,350 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-08-17 | 2,306 | $22.70 | 21,694 | No | 4 | S | Indirect | By Trust |
| Common Stock | Disposition | 2015-08-17 | 694 | $23.25 | 21,000 | No | 4 | S | Indirect | By Trust |
| Common Stock | Disposition | 2015-08-17 | 2,436 | $22.75 | 18,564 | No | 4 | S | Indirect | By Trust |
| Common Stock | Disposition | 2015-08-17 | 564 | $23.27 | 18,000 | No | 4 | S | Indirect | By Trust |
| Common Stock | Disposition | 2015-08-17 | 2,815 | $22.82 | 15,185 | No | 4 | S | Indirect | By Trust |
| Common Stock | Disposition | 2015-08-17 | 185 | $23.38 | 15,000 | No | 4 | S | Indirect | By Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
| No | 4 | S | Indirect | By Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-08-17 | 65,000 | $0.00 | 65,000 | $3.22 |
| Common Stock | Stock Option (right to buy) | Disposition | 2015-08-17 | 51,000 | $0.00 | 51,000 | $10.20 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 125,000 | 2020-02-10 | No | 4 | M | Direct | |
| 93,000 | 2024-02-27 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.99, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.46, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $22.15 to $23.10, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4.
- Shares are held in trusts, of which Mr. Migausky is the trustee, for the benefit of each of Mr. Migausky's children. Mr. Migausky disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $23.15 to $23.47, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 6.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $22.16 to $23.15, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 7.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $23.17 to $23.47, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 8.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $22.29 to $23.27, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 9.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $23.30 to $23.47, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 10.
- The options became fully exercisable on February 10, 2014.
- The options become exercisable in 48 substantially equal installments at the end of each monthly anniversary of the date of grant, February 27, 2014.
Billionaire Hedge Funds
